Women and Cardiovascular Heart Disease: Clinical Implications from the Women's Ischemia Syndrome Evaluation (Wise) Study. Are We Smarter?
From: Division of Cardiovascular Disease and Department of Internal Medicine, Mayo College of Medicine, Rochester, Minnesota 55902, USA.
Journal of the American College of Cardiology
- Publish Date: Feb 2006
- ISSN: 1558-3597
- Volume: 47
- Issue: 3 Suppl
- Pages: S59-62
- Medium: Internet
- Language: English
- Citation (JAMA): Lerman Amir, Sopko George, et al. Women and Cardiovascular Heart Disease: Clinical Implications from the Women's Ischemia Syndrome Evaluation (Wise) Study. Are We Smarter?. J. Am. Coll. Cardiol. Feb 2006;47:S59-62
Abstract
Review of the trend in cardiovascular disease mortality for males and females clearly demonstrated that whereas the trend shows a decline in males this decline is not observed in females. Multiple important reports emerged from the initial phases of the Women’s Ischemic Syndrome Evaluation (WISE) study that may have significant clinical implications for our approach to cardiovascular disease in women. The data derived from the WISE study certainly provided important information to our understanding of the approach to women with cardiovascular disease. The clinical presentation may be different, and a gender-oriented questionnaire may enhance our diagnosis. In a multivariable model, low hemoglobin was associated with significantly higher risk of adverse outcomes. The risk factor assessment and the risk factor profiles in women that are associated with coronary artery disease may be different. Based on the studies from the WISE study, metabolic syndrome is a leading and a major risk factor in women. Moreover, the data further support the concept that the mechanism of ischemia in women may be localized in the microvascular coronary arteries. Therefore, the diagnoses of coronary microvascular dysfunction or endothelial dysfunction should be considered in women with chest pain who do not have obstructive coronary artery disease. It may be advantageous to add such diagnostic tests when the conventional tests are nondiagnostic. A revised clinical approach to cardiovascular disease in women may be designed and tested based on these findings.
Mesh Headings (Keywords): Cardiovascular Diseases, Coronary Angiography, Female, Humans, Risk Factors, Sex Factors
Check for Full Text / PubMed Unique Identifier (PMID): 16458173
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.